Chronic pain is rarely one thing. It’s a mix of irritated tissues, sensitised nerves and movement avoidance that gradually shrinks capacity. Photobiomodulation (PBM) delivered via the K-Laser Cube adds a non-invasive tool to this picture: multi-wavelength red/near-infrared light (660/800/905/970 nm) is dosed to modulate inflammation, perfusion and mitochondrial signalling so people can move more easily, and more often. The Cube platform’s four wavelengths target different chromophores and depths in the same session, offering flexibility for superficial and deep pain generators alike.
What the evidence says about PBM for pain
Across pain conditions, recent reviews report clinically meaningful reductions in pain and improvements in function with PBM, particularly when paired with exercise-based rehabilitation. A 2023 synthesis concluded PBM shows beneficial effects on chronic pain and inflammation, while calling for tighter protocol standardisation—something a clinician-set, multi-wavelength device directly supports.
Knee osteoarthritis is a good example. Meta-analytic work indicates pain/disability benefits at 785–860 nm (4–8 J per point) and 904 nm (1–3 J per point)—wavelengths and doses that map cleanly onto Cube’s diode mix and dosing ranges. More recent summaries echo these parameter windows and suggest programmes of 10–16 sessions, two times per week, can be effective for short-term pain relief when integrated with strengthening. At the same time, not all trials are positive: a 2023 RCT adding PBM to quadriceps strengthening for knee OA reported no incremental improvement versus exercise alone—an important reminder that correct dosing, targeting and patient selection matter.
For back pain, emerging “high-intensity” and class IV laser literature—broader than any single manufacturer—suggests pain intensity reductions and potential disability improvements, though heterogeneity remains and protocols must be individualised.
Why the Cube’s wavelength mix is relevant
- 660 nm (red): superficial targets; may support microcirculation and early inflammatory modulation near the surface.
- 800 nm (near-IR): deeper tissue penetration for muscle and fascia.
- 905 nm (super-pulsed, near-IR): strong evidence base in OA parameters; useful per-point dosing windows are well described in reviews.
- 970 nm (near-IR/water absorption): thermal-leaning energy that can enhance perfusion without ablating tissue when used in PBM dosing ranges. Together, these enable layered treatments—useful when pain involves mixed superficial/deep drivers (e.g., paraspinal trigger points over facet-mediated low back pain).
In practice: pairing comfort with progression
In clinic, we time PBM to reduce pain before loading, then reinforce progress with graded exercise. This matches the evidence trend: light can help people tolerate movement, but loading is what rebuilds capacity. For knee OA, that’s typically quads/hip strengthening and gait work; for lumbar pain, spinal control and hip mobility. PBM is a tool that unlocks the plan—not a replacement for it.
Safety and expectations
PBM is generally well tolerated when delivered with eye protection and clinician-set doses. Expect short, comfortable sessions, a stepped plan (often 2×/week initially), and regular functional check-ins so dosing evolves with your progress. Early gains are usually in comfort and movement tolerance; sustained gains come from consistent rehab.
Visit our clinic in West Hampstead to explore the K-Laser Blue machine and how it could help you today.
